Granules India (GRANULES) Share Price Fall Streak: Stock slips 4.58%

Granules India Share Price Fall Streak has extended to a second straight session, with the stock last traded at Rs 828 after a cumulative 4.58% decline from Rs 867.7. According to Univest data, the pattern is confirmed, but no company-specific catalyst is established. The move matters because it is now a two-session sequence rather than a one-day drop, which changes how readers should read the stock’s behaviour around Granules India Share Price Fall Streak.

With a market capitalisation of Rs 23,669.11 Cr, Granules India Share Price Fall Streak is being watched as a large-cap healthcare name rather than a small event-driven laggard. In a streak context, the latest slip is not just about one trading day; it shows that the stock has stayed under pressure across consecutive sessions, which can matter more to readers than a single isolated decline. Granules India Share Price Fall Streak therefore deserves a closer look through price action, valuation and sector positioning.

Granules India (GRANULES) Share Price Fall Streak: Consecutive Decline Analysis

Metric	Value
Current Price	Rs 828
Previous Close	Rs 847.35
Today's Move	-Rs 19.35 (-2.28%)
Open	Rs 842
High	Rs 845.95
Low	Rs 822.9
Market Capitalisation	Rs 23,669.11 crore

Granules India Share Price Fall Streak traded at Rs 828 versus the previous close of Rs 847.35, marking a fall of Rs 19.35 or 2.28% in the latest session. The stock opened at Rs 842, touched a high of Rs 845.95 and a low of Rs 822.9, so the last traded price sat closer to the lower end of the day’s range. For readers following Granules India Share Price Fall Streak, that placement inside the range is important because it shows how the session unfolded without turning the move into a broader prediction.

The company’s market capitalisation stood at Rs 23,669.11 Cr, which keeps Granules India Share Price Fall Streak in the large-cap category. The latest move follows a cumulative 4.58% fall across the second straight session, with the streak beginning from Rs 867.7. For Granules India Share Price Fall Streak, the relevant point is not only the one-session drop but the fact that the stock has stayed lower on two consecutive trading days. That is why the current share price remains central to the stock news flow, and the next section looks at whether the streak changes the valuation read.

What the Consecutive Declines Show

Granules India Share Price Fall Streak now reflects a second straight session of lower closes, and the cumulative move of 4.58% from Rs 867.7 to Rs 828 gives the pattern more weight than a one-day move would. According to latest Univest figures, the data confirms the streak itself, while still stopping short of naming a cause. For a reader, that means the current Granules India Share Price Fall Streak should be read as a short sequence of weakness rather than a single intraday fluctuation.

The second straight session also helps separate price behaviour from business fundamentals. The earnings base behind Granules India Share Price Fall Streak does not change from one session to the next, but the price does, and that affects how valuation looks on the screen. In that sense, the streak lens is useful: it shows how the same company can move from one session to the next even when the underlying financial ratios stay fixed. Granules India Share Price Fall Streak is therefore a question of market pricing first, and company data second.

Granules India (GRANULES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 23,669.11 crore
P/E Ratio	34.9x
P/B Ratio	4.72x
ROE	14.13%
ROCE	15.74%
EPS	Rs 24.28
Book Value Per Share	Rs 179.7
Dividend Yield	0.21%

Granules India (GRANULES) fundamental metrics show P/E 34.9x, P/B 4.72x, ROE 14.13%, ROCE 15.74%. Taken on their own, these numbers offer context rather than a trading signal.

Granules India has a market capitalisation of Rs 23,669.11 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.9x, P/B at 4.72x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 24.28, book value per share of Rs 179.7, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	34.9x
Benchmark Median P/E	32.02x
Benchmark Average P/E	49.17x
Benchmark P/E Range	3.4x to 688.17x
Company P/B Ratio	4.72x
Benchmark Median P/B	2.94x
Benchmark Average P/B	4.37x
Company ROE	14.13%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.68%
Company ROCE	15.74%
Benchmark Median ROCE	13.61%
Benchmark Average ROCE	13.4%
Company Market Capitalisation	Rs 23,669.11 crore
Benchmark Median Market Cap	Rs 770.9 crore
Benchmark Average Market Cap	Rs 14,358.25 crore

Granules India (GRANULES) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Granules India (GRANULES) has a P/E ratio of 34.9x, which is above the benchmark median of 32.02x, a difference of +8.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Granules India (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.7%, a difference of +20.77%. Granules India (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.61%, a difference of +15.65%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,46,276.3	36.1	5.05	14.85	19.11
Divi's Laboratories	DIVISLAB	2,51,531.48	84.24	13.95	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,86,956.51	83.74	20.35	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,19,221.66	25.71	4.3	19.69	21.39
Cipla	CIPLA	1,11,728.51	32.36	3.1	11.83	16

Granules India (GRANULES) has a P/E ratio of 34.9x compared with the displayed peer median of 36.1x. The comparison is relative and should not be read as a recommendation. Its ROE of 14.13% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India (GRANULES) has a market capitalisation of Rs 23,669.11 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Granules India

• Granules India Share Price Fall Streak has now lasted for a second straight session, which makes the move more relevant than a single-day decline.
• The stock last traded at Rs 828, with the latest session showing a 2.28% fall from the previous close.
• Granules India Share Price Fall Streak still has a P/E of 34.9 and P/B of 4.72, so valuation remains a live part of the discussion.
• ROE of 14.13% and ROCE of 15.74% keep the company above the same-industry median on return efficiency.
• The large-cap market capitalisation of Rs 23,669.11 Cr places Granules India Share Price Fall Streak within a well-followed healthcare universe.

About Granules India

Granules India Share Price Fall Streak belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The business context that matters for the streak is straightforward: the company operates in a sector where valuation, return ratios and market capitalisation are often compared closely across listed names. Granules India Share Price Fall Streak is therefore being watched not just for the two-session decline, but also for how the market is pricing the company against other drug makers and healthcare names.

For a reader trying to interpret Granules India Share Price Fall Streak, the key business takeaway is that this is a large-cap pharmaceutical company with earnings, book value and return metrics already in view. The streak does not change the business model; it changes the market price attached to it. That is why the current stock analysis focuses on the relationship between the decline and the valuation that the market is assigning today.

Track Granules India Share Price on Univest

Use Granules India (GRANULES) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track Granules India Share Price Fall Streak on Univest for live share price updates, valuation ratios, market capitalisation, 52-week levels and company insights. The same page also helps users follow Granules India Share Price Fall Streak alongside peer data, sector context and key financial ratios in one place. For investors monitoring price action, that makes the stock easier to watch without losing the broader fundamentals.

Frequently Asked Questions

Why is Granules India Share Price Fall Streak in focus today?

Ans. Granules India Share Price Fall Streak is in focus because it has now fallen for a second straight session. The latest trade was Rs 828, and the cumulative decline across the streak is 4.58% from Rs 867.7.

What is the latest price in Granules India Share Price Fall Streak?

Ans. Granules India Share Price Fall Streak last traded at Rs 828. That came after a previous close of Rs 847.35, with the stock down Rs 19.35 or 2.28% in the latest session.

How did Granules India Share Price Fall Streak move during the day?

Ans. Granules India Share Price Fall Streak opened at Rs 842, touched a high of Rs 845.95 and a low of Rs 822.9. The last traded price sat near the lower end of that range.

What does the two-session decline mean for Granules India Share Price Fall Streak?

Ans. A second straight session of decline means the move is no longer an isolated fall. Granules India Share Price Fall Streak now reflects a short streak of lower closes, which changes the way readers interpret the price action.

Is Granules India Share Price Fall Streak expensive on valuation?

Ans. Granules India Share Price Fall Streak trades at a P/E of 34.9 and a P/B of 4.72. Those levels are above the same-industry median on both counts, so valuation remains elevated versus the benchmark middle.

How does Granules India Share Price Fall Streak compare with peers?

Ans. Granules India Share Price Fall Streak sits around the middle of the peer set on P/E and stands ahead of some peers on ROE and ROCE. It also has a Rs 23,669.11 Cr market capitalisation.

What do ROE and ROCE show in Granules India Share Price Fall Streak?

Ans. Granules India Share Price Fall Streak shows ROE of 14.13% and ROCE of 15.74%. Both are above the same-industry median, which means the company’s return efficiency remains visible even after the decline.

Where can readers track Granules India Share Price Fall Streak next?

Ans. Readers can track Granules India Share Price Fall Streak on Univest for live share price, valuation ratios, market capitalisation and sector context. That keeps the price action and fundamentals in one view.